| Bioactivity | EGFR/ C-Met-in-2 (Compound H-22) is a dual inhibitor of EGFR/c-Met. EGFR/c-Met-IN-2 inhibits cell proliferation by arresting G2/M phase. EGFR/c-Met-IN-2 has antitumor activity[1]. |
| Name | EGFR/c-Met-IN-2 |
| CAS | 2761180-01-0 |
| Formula | C27H23F2N5O4 |
| Molar Mass | 519.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhang H, et al. Novel quinazoline-based dual EGFR/c-Met inhibitors overcoming drug resistance for the treatment of NSCLC: Design, synthesis and anti-tumor activity. Bioorg Chem. 2024 Jan;142:106938. |
EGFR/c-Met-IN-2
CAS: 2761180-01-0 F: C27H23F2N5O4 W: 519.50
EGFR/ C-Met-in-2 (Compound H-22) is a dual inhibitor of EGFR/c-Met. EGFR/c-Met-IN-2 inhibits cell proliferation by arres
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.